Portfolio company
RadaHaim
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides scalable organoid mass production platforms and research services to pharmaceutical firms and clinicians for drug discovery and toxicity screening.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
Organo-ID
The company develops 3D organoid models and drug response tests for cancer patients and pharmaceutical researchers to improve personalised medicine and treatment efficacy.
BioHive
BioHive provides skin organoids derived from stem cells to pharmaceutical and dermocosmetic companies for toxicity and efficacy testing.
Revalia
This company provides a platform for testing drug candidates on functional human organs to provide preclinical data for pharmaceutical and biotechnology firms.
Orgonex
Orgonex develops automated bioreactor systems for organoid cultivation to assist researchers and pharmaceutical companies with large-scale cell expansion and drug development.
Kadis Bio
This biotech developer produces induced pluripotent stem cell-derived therapies and cardiac organoids for patients with cardiovascular diseases and pharmaceutical companies conducting drug toxicity testing.
Oncosyne
This company develops patient-derived tumoroid drug screening platforms for pharmaceutical firms and oncologists to improve drug discovery and personalised cancer treatment.
Bullseye Bio
This company develops vascularised organoids and automated screening platforms to provide drug discovery services for pharmaceutical, academic and biotechnology organisations.
